Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Accounts Payables: 2024-2025

Historic Accounts Payables for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $9.8 million.

  • Pyxis Oncology's Accounts Payables rose 100.33% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year increase of 100.33%. This contributed to the annual value of $4.9 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Accounts Payables is $9.8 million, which was up 3.65% from $9.4 million recorded in Q2 2025.
  • Pyxis Oncology's 5-year Accounts Payables high stood at $9.8 million for Q3 2025, and its period low was $2.3 million during Q1 2024.
  • For the 2-year period, Pyxis Oncology's Accounts Payables averaged around $5.6 million, with its median value being $4.9 million (2024).
  • Data for Pyxis Oncology's Accounts Payables shows a peak YoY surged of 100.33% (in 2025) over the last 5 years.
  • Pyxis Oncology's Accounts Payables (Quarterly) stood at $4.9 million in 2024, then soared by 100.33% to $9.8 million in 2025.
  • Its Accounts Payables stands at $9.8 million for Q3 2025, versus $9.4 million for Q2 2025 and $2.8 million for Q1 2025.